All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-MV-01LX192 | Anti-ANTXR1 (1D2) h(CD28-CD3ζ) CAR, pMMLV | Human | 1D2 | Mouse | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX193 | Anti-ANTXR1 (T803) h(CD28-CD3ζ) CAR, pMMLV | Human | T803 | Humanized | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX194 | Anti-ANTXR1 (M830) h(CD28-CD3ζ) CAR, pMMLV | Human | M830 | Human | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX195 | Anti-ANTXR1 (L3) h(CD28-CD3ζ) CAR, pMMLV | Human | L3 | Human | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX196 | Anti-ANTXR1 (L1) h(CD28-CD3ζ) CAR, pMMLV | Human | L1 | Human | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX436 | Anti-ANTXR1 (L2) h(41BB-CD3ζ) CAR, pMMLV | Human | L2 | Mouse | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX437 | Anti-ANTXR1 (1D2) h(41BB-CD3ζ) CAR, pMMLV | Human | 1D2 | Mouse | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX438 | Anti-ANTXR1 (T803) h(41BB-CD3ζ) CAR, pMMLV | Human | T803 | Humanized | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX439 | Anti-ANTXR1 (M830) h(41BB-CD3ζ) CAR, pMMLV | Human | M830 | Human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX440 | Anti-ANTXR1 (L3) h(41BB-CD3ζ) CAR, pMMLV | Human | L3 | Human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX441 | Anti-ANTXR1 (L1) h(41BB-CD3ζ) CAR, pMMLV | Human | L1 | Human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-SB-02LX188 | Anti-ANTXR1 (L2) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | L2 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX189 | Anti-ANTXR1 (1D2) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | 1D2 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX190 | Anti-ANTXR1 (T803) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | T803 | Humanized | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX191 | Anti-ANTXR1 (M830) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | M830 | Human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX192 | Anti-ANTXR1 (L3) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | L3 | Human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX193 | Anti-ANTXR1 (L1) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | L1 | Human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX430 | Anti-ANTXR1 (L2) h(CD28-OX40-CD3ζ) CAR, pSBCAR1 | Human | L2 | Mouse | scFv-CD28-OX40-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX431 | Anti-ANTXR1 (1D2) h(CD28-OX40-CD3ζ) CAR, pSBCAR1 | Human | 1D2 | Mouse | scFv-CD28-OX40-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX432 | Anti-ANTXR1 (T803) h(CD28-OX40-CD3ζ) CAR, pSBCAR1 | Human | T803 | Humanized | scFv-CD28-OX40-CD3ζ | Sleeping Beauty (SB) transposon | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION